Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis
2025 · Clinical and Experimental Medicine · 1 citations
https://doi.org/10.1007/s10238-025-01738-4